Original Research: Biomarker Testing in a Canadian Centre for Patients with Non‑small Cell Lung Cancer: Assessing Residual Risks. Can Oncol Today [Internet]. 2025 Nov. 5 [cited 2026 Apr. 6];2(3):22–28. Available from: https://canadianoncologytoday.com/article/view/2-3-Liu_et_al